Abstract Details
|
Bryson Hewins
PRESENTER |
Mr. Hewins has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| Josephine Pierce Pucci, MD | Ms. Pucci has a non-compensated relationship as a co-founder with Headway Foundation that is relevant to AAN interests or activities. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Kimbra L. Kenney, MD, FAAN | Dr. Kenney has nothing to disclose. |
| J. Kent Werner, Jr., MD, PhD (Uniformed Services University) | Dr. Werner has received personal compensation for serving as an employee of Cogentis Therapeutics. Dr. Werner has stock in Cogentis Therapeutics. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with United States Navy. Dr. Werner has received personal compensation in the range of $50,000-$99,999 for serving as a CEO / CoFounder with Cogentis Therapeutics. |